In the last 10 years, the clinical impact of VEGF expression has been a breakthrough, with an important link between tumor angiogenesis and survival, and the demonstration of a clinical benefit in inhibiting VEGF, increasing survival in patients with advanced malignancies. Here, VEGFA is linked to neoplasm.